BRAF and neoplasm: Many clinically used chemotherapeutics, such as paclitaxel [20], doxorubicin [21,22], cisplatin [21], BRAF inhibitors, MEK inhibitors [22], and sorafenib [23], have been reported to induce pyroptosis in tumor cells as part of their antitumor mechanisms.